iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Max Drawdown (5Y) : 89.47% for Aug. 31, 2025
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2025 | 89.47% |
| July 31, 2025 | 89.47% |
| June 30, 2025 | 89.47% |
| May 31, 2025 | 89.47% |
| April 30, 2025 | 89.47% |
| March 31, 2025 | 87.53% |
| February 28, 2025 | 85.42% |
| January 31, 2025 | 84.91% |
| December 31, 2024 | 84.91% |
| November 30, 2024 | 83.60% |
| October 31, 2024 | 82.34% |
| September 30, 2024 | 82.08% |
| August 31, 2024 | 82.08% |
| July 31, 2024 | 82.08% |
| June 30, 2024 | 82.08% |
| May 31, 2024 | 82.08% |
| April 30, 2024 | 82.08% |
| March 31, 2024 | 82.08% |
| February 29, 2024 | 82.08% |
| January 31, 2024 | 82.08% |
| December 31, 2023 | 82.08% |
| November 30, 2023 | 82.08% |
| October 31, 2023 | 82.08% |
| September 30, 2023 | 77.12% |
| August 31, 2023 | 76.12% |
| Date | Value |
|---|---|
| July 31, 2023 | 73.32% |
| June 30, 2023 | 72.98% |
| May 31, 2023 | 72.98% |
| April 30, 2023 | 72.98% |
| March 31, 2023 | 72.80% |
| February 28, 2023 | 65.38% |
| January 31, 2023 | 65.38% |
| December 31, 2022 | 65.38% |
| November 30, 2022 | 65.38% |
| October 31, 2022 | 65.38% |
| September 30, 2022 | 65.38% |
| August 31, 2022 | 65.38% |
| July 31, 2022 | 65.38% |
| June 30, 2022 | 65.38% |
| May 31, 2022 | 65.38% |
| April 30, 2022 | 59.50% |
| March 31, 2022 | 59.50% |
| February 28, 2022 | 59.50% |
| January 31, 2022 | 59.50% |
| December 31, 2021 | 59.50% |
| November 30, 2021 | 59.50% |
| October 31, 2021 | 59.50% |
| September 30, 2021 | 59.50% |
| August 31, 2021 | 59.50% |
| July 31, 2021 | 59.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ZimVie, Inc. (DELISTED) | -- |
| Sarepta Therapeutics, Inc. | 93.33% |
| Black Titan Corp. | 99.91% |
| Solid Biosciences, Inc. | 99.65% |
| Replimune Group, Inc. | 95.70% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.37 |
| Beta (5Y) | 1.313 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.11% |
| Historical Sharpe Ratio (5Y) | -0.347 |
| Historical Sortino (5Y) | -0.5966 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.03% |